What is Zoetis's dogs and cats — revenue?

Zoetis (ZTS) reported dogs and cats — revenue of $1.44B in Q1 2026.

How has Zoetis's dogs and cats — revenue changed year-over-year?

Zoetis's dogs and cats — revenue decreased by 2.3% year-over-year, from $1.48B to $1.44B.

What does dogs and cats — revenue mean?

This metric represents the total gross sales generated from products specifically designed for companion animals, including dogs and cats. It encompasses revenue streams from anti-infectives, vaccines, parasiticides, and diagnostic tools tailored to the veterinary care market for household pets. This segment is a primary driver of growth for the company, reflecting consumer demand for premium pet healthcare and wellness solutions.

Zoetis ZTS Dogs and Cats — Revenue

Other product segments

Horses

$5.8B+13.9%

Parasiticides

$586M+2.4%

Vaccines

$519M+18.2%

Cattle

$399M-0.5%

Dermatology

$349M-7.9%

Anti-infectives

$241M+1.3%

Pain and sedation

$203M-1.9%

Other pharmaceutical

$158M0.0%

Swine

$128M-7.9%

Animal health diagnostics

$117M+12.5%

Poultry

$117M-7.9%

Other Non Pharmaceuticals

$66M-7.0%

Fish

$65M+4.8%

Contract manufacturing & human health

$23M-23.3%

Sheep and other

$17M+6.3%

Similar metrics at other companies

CENTDog & cat products — Revenue

$148.2M-1.3%

ELANPet Health — Revenue

$710M+11.8%

CENTOther pet products — Revenue

$150.65M-5.1%

CORAnimal Health — Revenue

$1.44B+5.3%

CENTDog and cat products — Net Sales

$157.4M+14.6%

NEOGAnimal Care And Other — Revenue

$5.9M-43.3%

Other financials

Income statement

See full

Revenue$2.3B+2.9%

Gross profit$1.6B+2.6%

Net income$601.0M-0.2%

EPS (diluted)$1.42+6.0%

Balance sheet

See full

Cash & equivalents$1.9B+8.9%

Total debt$10.0B+48.0%

Total equity$3.2B-30.5%

Total assets$15.2B+7.5%

Cash flow

See full

Operating cash flow$401.0M-22.1%

CapEx$110.0M-38.2%

Free cash flow$291.0M-13.6%

Valuation

See full

Market cap$31.9B-54.6%

Enterprise value$39.95B-47.2%

P/E12.1×-15.1×

P/S3.4×-4.1×

Profitability

See full

Gross margin71.8%+0.8pp

Net margin27.8%+0.9pp

FCF margin23.5%0.0pp

Returns & leverage

See full

Return on equity67%+15.8pp

Debt / equity3.1×+1.6×

Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's dogs and cats — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zoetis's dogs and cats — revenue?: Zoetis (ZTS) reported dogs and cats — revenue of $1.44B in Q1 2026.
How has Zoetis's dogs and cats — revenue changed year-over-year?: Zoetis's dogs and cats — revenue decreased by 2.3% year-over-year, from $1.48B to $1.44B.
What does dogs and cats — revenue mean?: This metric represents the total gross sales generated from products specifically designed for companion animals, including dogs and cats. It encompasses revenue streams from anti-infectives, vaccines, parasiticides, and diagnostic tools tailored to the veterinary care market for household pets. This segment is a primary driver of growth for the company, reflecting consumer demand for premium pet healthcare and wellness solutions.